156 related articles for article (PubMed ID: 18289105)
21. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase.
Huse JT; Pijak DS; Leslie GJ; Lee VM; Doms RW
J Biol Chem; 2000 Oct; 275(43):33729-37. PubMed ID: 10924510
[TBL] [Abstract][Full Text] [Related]
22. Evidence for dimeric BACE-mediated APP processing.
Jin S; Agerman K; Kolmodin K; Gustafsson E; Dahlqvist C; Jureus A; Liu G; Fälting J; Berg S; Lundkvist J; Lendahl U
Biochem Biophys Res Commun; 2010 Feb; 393(1):21-7. PubMed ID: 20097169
[TBL] [Abstract][Full Text] [Related]
23. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
[TBL] [Abstract][Full Text] [Related]
24. BACE is degraded via the lysosomal pathway.
Koh YH; von Arnim CA; Hyman BT; Tanzi RE; Tesco G
J Biol Chem; 2005 Sep; 280(37):32499-504. PubMed ID: 16033761
[TBL] [Abstract][Full Text] [Related]
25. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features.
Shimmyo Y; Kihara T; Akaike A; Niidome T; Sugimoto H
Biochim Biophys Acta; 2008 May; 1780(5):819-25. PubMed ID: 18295609
[TBL] [Abstract][Full Text] [Related]
26. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
[TBL] [Abstract][Full Text] [Related]
27. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase.
Bennett BD; Denis P; Haniu M; Teplow DB; Kahn S; Louis JC; Citron M; Vassar R
J Biol Chem; 2000 Dec; 275(48):37712-7. PubMed ID: 10956649
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of BACE, a promising approach to Alzheimer's disease therapy.
Roggo S
Curr Top Med Chem; 2002 Apr; 2(4):359-70. PubMed ID: 11966460
[TBL] [Abstract][Full Text] [Related]
29. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
30. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an Allosteric BACE Inhibitor Peptide to Identify Mimetics that Can Interact with the Loop F Region of the Enzyme and Prevent APP Cleavage.
Campagna J; Vadivel K; Jagodzinska B; Jun M; Bilousova T; Spilman P; John V
J Mol Biol; 2018 May; 430(11):1566-1576. PubMed ID: 29649434
[TBL] [Abstract][Full Text] [Related]
32. Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases.
Grüninger-Leitch F; Schlatter D; Küng E; Nelböck P; Döbeli H
J Biol Chem; 2002 Feb; 277(7):4687-93. PubMed ID: 11741910
[TBL] [Abstract][Full Text] [Related]
33. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
34. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.
Cordy JM; Hussain I; Dingwall C; Hooper NM; Turner AJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11735-40. PubMed ID: 14504402
[TBL] [Abstract][Full Text] [Related]
35. Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo.
Machauer R; Laumen K; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Jaton AL; Desrayaud S; Staufenbiel M; Rabe S; Paganetti P; Neumann U
Bioorg Med Chem Lett; 2009 Mar; 19(5):1366-70. PubMed ID: 19195887
[TBL] [Abstract][Full Text] [Related]
36. 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.
Baxter EW; Conway KA; Kennis L; Bischoff F; Mercken MH; Winter HL; Reynolds CH; Tounge BA; Luo C; Scott MK; Huang Y; Braeken M; Pieters SM; Berthelot DJ; Masure S; Bruinzeel WD; Jordan AD; Parker MH; Boyd RE; Qu J; Alexander RS; Brenneman DE; Reitz AB
J Med Chem; 2007 Sep; 50(18):4261-4. PubMed ID: 17685503
[TBL] [Abstract][Full Text] [Related]
37. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
38. A general procedure for the purification of human beta-secretase expressed in Escherichia coli.
Sardana V; Xu B; Zugay-Murphy J; Chen Z; Sardana M; Darke PL; Munshi S; Kuo LC
Protein Expr Purif; 2004 Apr; 34(2):190-6. PubMed ID: 15003250
[TBL] [Abstract][Full Text] [Related]
39. Human beta-secretase (BACE) and BACE inhibitors: progress report.
John V
Curr Top Med Chem; 2006; 6(6):569-78. PubMed ID: 16712492
[TBL] [Abstract][Full Text] [Related]
40. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
